Nicotinamide Riboside Supplementation for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Midlife and Older Adults is a research paper published in Frontiers in Cardiovascular Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 21 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01AG061514
National Institutes of Health
Grant: F31HL154782
National Institutes of Health
Grant: K01HL153326
National Institutes of Health
Grant: K01AG054731
National Institutes of Health
Grant: 5K01AG054731-06
NAD+ Therapy for Improving Memory & Cerebrovasular Function in Patients with MCI
National Institutes of Health
Grant: 1F31HL154782-01
Nicotinamide Riboside Supplementation for Decreasing Inflammation in Middle-Aged and Older Adults
National Institutes of Health
Grant: 3R01AG061514-01S1
Nicotinamide riboside supplementation for treating elevated systolic blood pressure and arterial stiffness in middle-aged and older adults
National Institutes of Health
Grant: 5K01HL153326-04
Novel time-efficient inspiratory muscle strength training for lowering systolic blood pressure and improving endothelial, cerebrovascular, and cognitive function
Fields of Study
Keywords
Sustainable Development Goals